SEC Form 4 · accession 0001534122-15-000067
Cell MedX Corp. · CMXC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank McEnulty
Officer — PRESIDENT AND CEO · Director
Period of report
Aug 5, 2015
Accepted (ET)
Aug 6, 2015 · 2:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001493712
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $0.30 | Aug 5, 2015 | A | 500,000 | A | Aug 5, 2015 | Aug 5, 2020 | Common Stock | 500,000 | 500,000 | D |
| Stock Options (Right to Buy) | $0.30 | Aug 5, 2015 | A | 500,000 | A | Oct 1, 2015 | Oct 1, 2020 | Common Stock | 500,000 | 500,000 | D |
| Stock Options (Right to Buy) | $0.30 | Aug 5, 2015 | A | 500,000 | A | Jan 1, 2016 | Jan 1, 2021 | Common Stock | 500,000 | 500,000 | D |
| Stock Options (Right to Buy) | $0.30 | Aug 5, 2015 | A | 500,000 | A | Apr 1, 2016 | Apr 1, 2021 | Common Stock | 500,000 | 500,000 | D |
| Stock Options (Right to Buy) | $0.30 | Aug 5, 2015 | A | 500,000 | A | Jul 1, 2016 | Jul 1, 2021 | Common Stock | 500,000 | 500,000 | D |
Remarks
The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of any of the equity securities listed in this statement for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.